{"gene":"PEX5L","run_date":"2026-06-10T05:19:53","timeline":{"discoveries":[{"year":2009,"finding":"TRIP8b (PEX5L) exists as at least nine alternative N-terminal splice isoforms in brain and functions as an auxiliary subunit of HCN1 channels: all isoforms inhibit channel opening by shifting activation to more negative potentials, while individual isoforms differentially downregulate or upregulate HCN1 surface expression.","method":"Heterologous expression of splice isoforms, electrophysiology, surface expression assays","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — replicated independently in two concurrent papers (PMID:19555649 and PMID:19439603) using electrophysiology and surface expression assays with multiple isoforms","pmids":["19555649","19439603"],"is_preprint":false},{"year":2009,"finding":"PEX5R/TRIP8b was identified as the beta (auxiliary) subunit of HCN channels in mammalian brain by affinity purification and high-resolution mass spectrometry; coassembly with PEX5R/TRIP8b largely impairs cAMP-dependent activation of HCN2 and HCN4, while gating by phosphoinositides and basal voltage-dependence remain unaffected; de novo expression of PEX5R/TRIP8b in cardiomyocytes abolishes beta-adrenergic stimulation of HCN channels.","method":"Affinity purification, high-resolution mass spectrometry, electrophysiology in heterologous cells and cardiomyocytes","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — biochemical identification by MS plus functional electrophysiology in multiple cell types, published alongside independent replication","pmids":["19555650"],"is_preprint":false},{"year":2001,"finding":"TRIP8b was identified as a Rab8b-interacting protein via yeast two-hybrid screen from rat brain cDNA; interaction was verified by in vitro binding and co-immunoprecipitation; TRIP8b is present in both cytosolic and membrane fractions of AtT20 cells; overexpression of TRIP8b stimulates cAMP-induced ACTH secretion, implicating it in the regulated secretory pathway.","method":"Yeast two-hybrid, in vitro binding, co-immunoprecipitation, subcellular fractionation, ACTH secretion assay in stable cell lines","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal binding confirmed by multiple methods in single lab","pmids":["11278749"],"is_preprint":false},{"year":2011,"finding":"TRIP8b knockout mice show dramatically reduced Ih in hippocampal pyramidal neurons due to reduction of HCN channels on the neuronal surface and disrupted dendritic localization of HCN channels; absence of TRIP8b increases HCN subunit targeting to and degradation by lysosomes.","method":"Knockout mouse, electrophysiology, immunohistochemistry, subcellular fractionation, lysosome trafficking assay","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with multiple orthogonal readouts (electrophysiology, localization, lysosomal degradation) in vivo and in vitro","pmids":["21593326"],"is_preprint":false},{"year":2011,"finding":"TRIP8b interacts with HCN1 at two distinct C-terminal sites: (1) an upstream site where the HCN1 C-linker/cyclic nucleotide-binding domain (CNBD) interacts with an 80 aa domain in the conserved core of TRIP8b — necessary and sufficient for inhibition of channel opening and sufficient for downregulatory trafficking effects; (2) a downstream site where the HCN1 C-terminal SNL tripeptide interacts with the TRIP8b tetratricopeptide repeat (TPR) domain — stabilizes the complex and is required for upregulatory trafficking effects.","method":"Mutagenesis, co-immunoprecipitation, electrophysiology in heterologous cells and neurons","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — systematic mutagenesis of both interaction sites combined with electrophysiology and trafficking assays, consistent with independent structural data","pmids":["21411649"],"is_preprint":false},{"year":2011,"finding":"Isoform-wide disruption of TRIP8b/HCN1 interaction causes HCN1 mistargeting throughout CA1 somatodendritic compartments; selective removal of exons 1b and 2 leaves two hippocampal isoforms — TRIP8b(1a-4) promotes HCN1 surface expression in dendrites while TRIP8b(1a) suppresses HCN1 misexpression in axons — demonstrating that proper distal dendritic localization requires additive and subtractive sculpting by two distinct isoforms.","method":"Knockout mouse (isoform-specific), isoform-wide interaction mutant, viral overexpression in neurons, immunohistochemistry","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — two complementary genetic mouse models with defined isoform rescue experiments","pmids":["21555075"],"is_preprint":false},{"year":2011,"finding":"Interaction of TRIP8b with the HCN1 C-terminal SNL tripeptide (via TPR domain) governs channel trafficking effects, whereas TRIP8b interaction with the HCN1 CNBD affects both trafficking and gating; cAMP directly disrupts TRIP8b binding to the CNBD (requiring an arginine residue also required for cAMP binding), and elevated cAMP antagonizes TRIP8b-mediated upregulation of HCN1.","method":"Site-directed mutagenesis, electrophysiology, co-immunoprecipitation, biochemical competition assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — mutagenesis of both interaction sites combined with electrophysiology and biochemical competition, consistent with independent structural studies","pmids":["21504900"],"is_preprint":false},{"year":2012,"finding":"TRIP8b and HCN2 form an obligate 4:4 (tetrameric) complex; the TRIP8b TPR region binds the HCN C-terminal SNL tripeptide and the TRIP8b conserved region binds the HCN CNBD; X-ray crystal structure of the TRIP8b TPR domain in complex with the HCN2 C-terminal peptide was determined.","method":"Single-molecule fluorescence bleaching, fluorescence-detection size-exclusion chromatography, fluorescence anisotropy, X-ray crystallography","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure plus multiple orthogonal biophysical methods establishing stoichiometry and binding sites","pmids":["22550182"],"is_preprint":false},{"year":2014,"finding":"NMR solution structure of the HCN2 CNBD (apo form) was determined and TRIP8b interaction site mapped; TRIP8b does not compete with cAMP for the same binding region on the CNBD but instead acts via an allosteric mechanism that prevents cAMP-induced conformational changes in the CNBD.","method":"NMR spectroscopy, structural mapping, conformational change analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structure with interaction site mapping in a single rigorous study","pmids":["25197093"],"is_preprint":false},{"year":2015,"finding":"EPR and NMR studies show that TRIP8b binds to the apo (cAMP-free) state of the HCN2 CNBD without changing the overall domain structure, and the binding interface on the CNBD was identified, providing a structural framework for TRIP8b's reduction of cyclic nucleotide dependence.","method":"Electron paramagnetic resonance (EPR), NMR spectroscopy","journal":"Structure","confidence":"High","confidence_rationale":"Tier 1 / Moderate — two independent spectroscopic structural methods in a single rigorous study","pmids":["25800552"],"is_preprint":false},{"year":2012,"finding":"TRIP8b is required for HCN1 trafficking to dendrites but presynaptic (axonal terminal) cortical HCN1 expression and function is comparable between TRIP8b-null and wild-type mice, demonstrating compartment-selective roles of TRIP8b in HCN channel trafficking.","method":"TRIP8b knockout mouse, electrophysiology, electron microscopy","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic KO with electrophysiology and EM in defined compartments","pmids":["23077068"],"is_preprint":false},{"year":2012,"finding":"Specific TRIP8b isoforms regulate axonal HCN1 trafficking in perforant path; TRIP8b(1a) isoform promotes somatodendritic and reduces axonal HCN1 expression when overexpressed in entorhinal neurons, whereas TRIP8b(1a-4) does not alter axonal distribution.","method":"Knockout mouse (isoform-specific), viral overexpression in cultured neurons, immunohistochemistry","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isoform-specific mouse and overexpression in neurons, single lab","pmids":["22363812"],"is_preprint":false},{"year":2008,"finding":"The TPR domains of Pex5Rp/TRIP8b and Pex5p have distinct but overlapping substrate specificities for Rab8b and PTS1-like C-terminal peptides; changes in surrounding residues or conformational state of binding partners alter binding activities, showing the binding specificity of the TRIP8b TPR domain is context-dependent.","method":"Biochemical binding assays, peptide competition, mutagenesis","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biochemical methods in a single lab study","pmids":["18346465"],"is_preprint":false},{"year":2014,"finding":"PEX5L acts as a co-receptor for PTS2-mediated peroxisomal import: in the presence of PEX5L, the interaction strength between PTS2 cargo and PEX7 is drastically increased; cargo binding is a prerequisite for PEX7–PEX5L interaction; overexpression of PTS2 cargo stimulates PEX7 transfer to peroxisomes, suggesting sequential formation of a trimeric cargo–PEX7–PEX5L complex is required for PTS2 import.","method":"Mammalian two-hybrid assay, overexpression, co-immunoprecipitation, peroxisomal transfer assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mammalian two-hybrid plus co-IP and peroxisomal transfer assays in single lab","pmids":["25538232"],"is_preprint":false},{"year":2008,"finding":"TRIP8b interacts with the calcium-independent receptor of alpha-latrotoxin (CIRL); affinity chromatography of brain extracts on immobilized TRIP8b identified clathrin and AP2 complex subunits as major TRIP8b-interacting proteins, suggesting a role in receptor-mediated endocytosis.","method":"Yeast two-hybrid, affinity chromatography, mass spectrometry","journal":"Biochemistry. Biokhimiia","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, affinity chromatography pulldown without reciprocal validation for most interactors","pmids":["18620529"],"is_preprint":false},{"year":2011,"finding":"TRIP8b directly interacts with clathrin through two short clathrin-binding motifs in its N-terminal (non-TPR) region; co-expression of HCN1 with TRIP8b in HEK293 cells translocates channels from cell surface to large intracellular puncta co-localizing with clathrin, early endosome, and lysosome markers; a clathrin-non-binding TRIP8b mutant fails to recruit clathrin to these puncta; TRIP8b is present in purified clathrin-coated vesicles from brain.","method":"In vitro binding assay, mutagenesis, co-immunoprecipitation, live/fixed cell imaging, purification of clathrin-coated vesicles","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro binding with mutagenesis plus cellular imaging and biochemical fractionation, single lab","pmids":["21749376"],"is_preprint":false},{"year":2017,"finding":"TRIP8b reduces cAMP affinity for the HCN2 CNBD; using fluorescence anisotropy, biolayer interferometry, and DEER spectroscopy, TRIP8b was found to act predominantly as a partial competitive antagonist of cAMP at the CNBD binding site, largely competing with a portion of the cAMP-binding pocket rather than exclusively acting noncompetitively.","method":"Fluorescence anisotropy, biolayer interferometry, double electron-electron resonance (DEER) spectroscopy, kinetic modeling","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — three independent biophysical methods with quantitative modeling in a single rigorous study; note partial contradiction with allosteric model from PMID:25197093","pmids":["28864772"],"is_preprint":false},{"year":2017,"finding":"Allosteric coupling between TRIP8b's TPR domains and its CNBD-binding domain confers binding specificity for HCN channels: binding at either the HCN CNBD site or the HCN C-terminal (SNL) site increases affinity at the other site, and this allostery also limits TRIP8b binding to PTS1-type substrates.","method":"Fluorescence polarization, co-immunoprecipitation, mutagenesis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two orthogonal binding assays with mutagenesis, single lab","pmids":["28887304"],"is_preprint":false},{"year":2016,"finding":"Restoration of TRIP8b expression to the hippocampus of TRIP8b KO mice (viral rescue) was sufficient to reverse both impaired HCN channel dendritic trafficking and antidepressant-like behavioral effects; a TRIP8b mutant further impairing HCN channel trafficking increased the antidepressant-like phenotype, demonstrating that TRIP8b-mediated HCN channel trafficking bidirectionally controls antidepressant-like behavior.","method":"Viral rescue in KO mice, mutagenesis, immunohistochemistry, behavioral assays","journal":"Molecular psychiatry","confidence":"High","confidence_rationale":"Tier 2 / Strong — bidirectional viral rescue in KO mice with orthogonal behavioral and cell biological readouts","pmids":["27400855"],"is_preprint":false},{"year":2019,"finding":"Phosphorylation of TRIP8b at Ser237 enhances its binding to HCN channels and influences channel gating by altering affinity for the HCN cytoplasmic domain; phospho-Ser237 TRIP8b is enriched in CA1 distal dendrites in vivo; this phosphorylation is reduced in the kainic acid model of TLE, correlating with HCN channel mislocalization.","method":"Phosphospecific antibody, co-immunoprecipitation, electrophysiology, immunohistochemistry, kainic acid TLE model","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — phosphospecific antibody with functional binding and electrophysiology assays, single lab","pmids":["31492750"],"is_preprint":false},{"year":2020,"finding":"Two point mutations (N/A and C/D) in the N-bundle loop of HCN connecting the CNBD to the C-linker strongly reduce TRIP8b binding to the CNBD without altering cAMP affinity, dissociating TRIP8b's gating effects from its trafficking effects in cortical neurons.","method":"Structure-guided mutagenesis, binding assays, electrophysiology in cortical neurons","journal":"The Journal of general physiology","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — rational structure-based mutagenesis validated functionally in neurons, single lab","pmids":["32633755"],"is_preprint":false},{"year":2022,"finding":"Single-molecule mass photometry of purified HCN4-TRIP8b complexes confirmed a 1:1 stoichiometry (four TRIP8b subunits per tetrameric HCN4 channel), independently validating the 4:4 stoichiometry reported by fluorescence bleaching.","method":"Single-molecule mass photometry","journal":"Frontiers in physiology","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — single biophysical method (mass photometry) in a single lab, replicates prior fluorescence bleaching result","pmids":["36225302"],"is_preprint":false},{"year":2014,"finding":"TRIP8b is required for maximal HCN1 expression in the retina: in TRIP8b KO mice, HCN1 total protein is greatly reduced in retinal neurons but HCN1 surface trafficking is unaffected, indicating that in photoreceptors TRIP8b controls HCN1 abundance rather than localization.","method":"Knockout mouse, immunohistochemistry, Western blot, confocal microscopy","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with two orthogonal readouts (protein level and trafficking), single lab","pmids":["24409334"],"is_preprint":false},{"year":2026,"finding":"A minimal peptide derivative of TRIP8b (TRIP8bnano) selectively prevents cAMP binding to the HCN2 CNBD and abolishes cAMP-mediated potentiation of HCN2 currents in dorsal root ganglion neurons; DRG-targeted expression of TRIP8bnano significantly reduced mechanical and thermal hypersensitivity in a rat neuropathic pain model.","method":"In vitro electrophysiology (HEK293T and DRG neurons), viral DRG expression, rat neuropathic pain behavioral assays","journal":"The Journal of physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional peptide inhibitor validated electrophysiologically and in vivo, single lab","pmids":["42010827"],"is_preprint":false}],"current_model":"PEX5L/TRIP8b is a brain-specific auxiliary subunit of HCN channels that exists as multiple alternative splice isoforms and binds HCN pore-forming subunits at two distinct C-terminal sites — the CNBD (via the TRIP8b conserved core) and the C-terminal SNL tripeptide (via the TRIP8b TPR domain) — forming an obligate 4:4 complex; binding at the CNBD site (primarily by competitive/allosteric antagonism of cAMP) inhibits channel opening and controls cAMP responsiveness, while N-terminal splice-isoform-specific trafficking motifs differentially up- or down-regulate HCN surface expression and dendritic vs. axonal localization; TRIP8b also interacts with clathrin and Rab8b to regulate HCN endocytosis and lysosomal degradation; phosphorylation of TRIP8b at Ser237 modulates its HCN-binding affinity; and independently, PEX5L acts as a co-receptor in PTS2-mediated peroxisomal import by forming a trimeric complex with PEX7 and PTS2 cargo to stabilize import."},"narrative":{"mechanistic_narrative":"PEX5L/TRIP8b is a brain-enriched auxiliary (beta) subunit of hyperpolarization-activated cyclic-nucleotide-gated (HCN) channels that controls both HCN gating and subcellular trafficking [PMID:19555649, PMID:19439603, PMID:19555650]. It binds the pore-forming HCN subunits at two distinct C-terminal sites: an upstream interaction between the TRIP8b conserved core and the HCN C-linker/cyclic nucleotide-binding domain (CNBD), which is necessary and sufficient to inhibit channel opening, and a downstream interaction between the TRIP8b tetratricopeptide-repeat (TPR) domain and the HCN C-terminal SNL tripeptide, which stabilizes the complex and drives upregulatory trafficking; binding at the two sites is allosterically coupled, conferring HCN binding specificity [PMID:21411649, PMID:22550182, PMID:28887304]. The structure of the TPR–SNL interface was solved crystallographically, and the assembled channel adopts an obligate 4:4 (one TRIP8b per HCN subunit) stoichiometry [PMID:22550182, PMID:36225302]. At the CNBD, TRIP8b binds the apo (cAMP-free) state and reduces cyclic-nucleotide sensitivity, acting predominantly as a partial competitive antagonist of cAMP, thereby suppressing cAMP/beta-adrenergic potentiation of HCN currents [PMID:19555650, PMID:28864772]. Through nine alternative N-terminal splice isoforms carrying distinct trafficking motifs and clathrin-binding sequences, TRIP8b sculpts HCN1 surface expression and somatodendritic-versus-axonal distribution, and routes HCN channels through clathrin-coated vesicles toward endosomes and lysosomes; loss of TRIP8b reduces dendritic Ih, mistargets HCN, and accelerates its lysosomal degradation [PMID:19555649, PMID:19439603, PMID:21555075, PMID:21749376, PMID:21593326]. TRIP8b-dependent HCN dendritic trafficking bidirectionally controls antidepressant-like behavior in mice, and Ser237 phosphorylation that enhances HCN binding is lost in a model of temporal lobe epilepsy, linking TRIP8b regulation to neuronal excitability disorders [PMID:27400855, PMID:31492750]. Independently of its channel role, PEX5L functions as a co-receptor for PTS2-mediated peroxisomal import, forming a trimeric cargo–PEX7–PEX5L complex in which cargo binding strengthens the PEX7 interaction [PMID:25538232].","teleology":[{"year":2001,"claim":"Before any channel role was known, the question was what cellular pathway TRIP8b participates in; identifying it as a Rab8b partner in the regulated secretory pathway gave the first functional foothold.","evidence":"Yeast two-hybrid from rat brain, in vitro binding, co-IP, and ACTH secretion assay in AtT20 cells","pmids":["11278749"],"confidence":"Medium","gaps":["Did not connect TRIP8b to HCN channels","Physiological relevance of Rab8b binding to endogenous trafficking unresolved"]},{"year":2008,"claim":"It was unclear how the TRIP8b TPR domain achieves binding specificity; comparison with Pex5p showed overlapping, context-dependent recognition of Rab8b and PTS1-like C-terminal peptides.","evidence":"Biochemical binding, peptide competition, and mutagenesis of TPR domains","pmids":["18346465"],"confidence":"Medium","gaps":["No HCN substrate tested here","Did not establish in-cell consequences of binding promiscuity"]},{"year":2009,"claim":"The defining advance was establishing TRIP8b as the HCN auxiliary beta subunit and showing it dually controls gating (inhibiting opening, suppressing cAMP/cyclic-nucleotide responsiveness) and isoform-dependent surface expression.","evidence":"Affinity purification + mass spectrometry, heterologous expression of multiple splice isoforms, electrophysiology, surface assays, and cardiomyocyte expression","pmids":["19555649","19439603","19555650"],"confidence":"High","gaps":["Molecular basis of the two binding sites not yet mapped","Stoichiometry of the complex unknown","Mechanism of cAMP antagonism unresolved"]},{"year":2011,"claim":"To explain how one protein both gates and traffics HCN, the two C-terminal interaction sites were dissected: the conserved-core/CNBD site mediates gating inhibition and downregulation, while the TPR/SNL site stabilizes the complex and drives upregulation, with cAMP directly disrupting CNBD binding.","evidence":"Systematic mutagenesis, co-IP, biochemical competition, and electrophysiology in heterologous cells and neurons","pmids":["21411649","21504900"],"confidence":"High","gaps":["Atomic structure of CNBD interface not yet solved","Quantitative stoichiometry still inferred"]},{"year":2011,"claim":"It was unknown how TRIP8b removes HCN from the surface; identification of two N-terminal clathrin-binding motifs and recruitment of HCN to clathrin/endosome/lysosome puncta defined the endocytic mechanism.","evidence":"In vitro binding, mutagenesis, co-IP, cell imaging, and purification of brain clathrin-coated vesicles","pmids":["21749376"],"confidence":"Medium","gaps":["Adaptor requirements (e.g., AP2) only partially defined","In vivo contribution of clathrin route to HCN turnover not quantified"]},{"year":2011,"claim":"To test physiological function, TRIP8b knockout and isoform-specific genetic models showed that proper distal dendritic HCN localization requires additive and subtractive sculpting by distinct isoforms, and that loss of TRIP8b reduces dendritic Ih and routes HCN to lysosomal degradation.","evidence":"Constitutive and isoform-specific knockout mice, viral isoform rescue, electrophysiology, immunohistochemistry, lysosome trafficking assays","pmids":["21593326","21555075"],"confidence":"High","gaps":["Trafficking machinery linking isoform motifs to compartments incompletely defined","Cell-type specificity beyond hippocampus not addressed"]},{"year":2012,"claim":"The stoichiometry and TPR-site structure were resolved, establishing an obligate 4:4 complex and the atomic basis of the TPR–SNL interaction.","evidence":"Single-molecule fluorescence bleaching, FSEC, fluorescence anisotropy, and X-ray crystallography of the TPR–HCN2 peptide complex","pmids":["22550182"],"confidence":"High","gaps":["CNBD-site structure not captured here","Conformational basis of cAMP antagonism still open"]},{"year":2012,"claim":"To determine whether TRIP8b acts uniformly across neuronal compartments, knockout and isoform-overexpression studies revealed compartment-selective roles, with dendritic HCN1 requiring TRIP8b while axonal/presynaptic HCN1 was largely TRIP8b-independent and shaped by specific isoforms.","evidence":"Isoform-specific knockout mice, viral overexpression, electrophysiology, electron microscopy, immunohistochemistry","pmids":["23077068","22363812"],"confidence":"High","gaps":["Mechanistic basis of axonal vs dendritic targeting differences unresolved","Isoform-specific binding partners not identified"]},{"year":2014,"claim":"The structural mechanism of cAMP desensitization was probed: NMR of the apo HCN2 CNBD mapped the TRIP8b site and indicated an allosteric mechanism preventing cAMP-induced conformational change rather than direct competition.","evidence":"NMR structure determination and interaction-site mapping with conformational analysis","pmids":["25197093"],"confidence":"High","gaps":["Allosteric vs competitive mechanism not definitively distinguished","Dynamics of the apo-state interaction unresolved"]},{"year":2014,"claim":"Two distinct roles outside the canonical model were established: TRIP8b controls HCN1 abundance (not surface trafficking) in retina, and PEX5L acts as a PTS2 import co-receptor via a cargo-dependent trimeric PEX7 complex.","evidence":"Knockout mouse with Western/immunohistochemistry (retina); mammalian two-hybrid, co-IP, and peroxisomal transfer assays (PTS2 import)","pmids":["24409334","25538232"],"confidence":"Medium","gaps":["Tissue basis for abundance-vs-localization role difference unknown","Structural basis of cargo–PEX7–PEX5L assembly not determined","Relationship between channel and peroxisomal functions of the same gene unresolved"]},{"year":2015,"claim":"Refining the CNBD mechanism, spectroscopic studies confirmed TRIP8b binds the apo CNBD without altering domain structure, providing a structural framework for reduced cyclic-nucleotide dependence.","evidence":"EPR and NMR spectroscopy with interface identification","pmids":["25800552"],"confidence":"High","gaps":["Did not resolve competitive component of antagonism","Kinetics of cAMP/TRIP8b exchange not measured"]},{"year":2016,"claim":"To connect molecular trafficking to behavior, viral rescue in TRIP8b KO mice demonstrated that TRIP8b-mediated HCN dendritic trafficking bidirectionally controls antidepressant-like behavior.","evidence":"Viral rescue with wild-type and trafficking-impairing mutants in KO mice, immunohistochemistry, behavioral assays","pmids":["27400855"],"confidence":"High","gaps":["Circuit-level mechanism linking Ih to behavior not defined","Whether other ion channels contribute unresolved"]},{"year":2017,"claim":"The cAMP-antagonism mechanism was quantitatively refined to a predominantly partial competitive model, and allosteric coupling between TPR and CNBD-binding domains was shown to set HCN binding specificity over PTS1-type substrates.","evidence":"Fluorescence anisotropy, biolayer interferometry, DEER spectroscopy, kinetic modeling (mechanism); fluorescence polarization, co-IP, mutagenesis (allostery)","pmids":["28864772","28887304"],"confidence":"High","gaps":["Partial contradiction with the purely allosteric model from earlier NMR work","Physiological switch between channel and peroxisomal binding not defined"]},{"year":2019,"claim":"Post-translational regulation was identified: Ser237 phosphorylation enhances HCN binding and influences gating, is enriched in distal dendrites, and is lost with HCN mislocalization in an epilepsy model.","evidence":"Phosphospecific antibody, co-IP, electrophysiology, immunohistochemistry, kainic acid TLE model","pmids":["31492750"],"confidence":"Medium","gaps":["Kinase/phosphatase regulating Ser237 not identified","Causal role of dephosphorylation in epileptogenesis not established"]},{"year":2020,"claim":"Gating and trafficking functions were genetically separated using HCN N-bundle-loop mutations that abolish TRIP8b CNBD binding without altering cAMP affinity.","evidence":"Structure-guided HCN mutagenesis, binding assays, electrophysiology in cortical neurons","pmids":["32633755"],"confidence":"Medium","gaps":["Mutations validated in a single neuronal context","In vivo consequences of selective uncoupling not tested"]},{"year":2022,"claim":"An independent biophysical method confirmed the one-TRIP8b-per-HCN-subunit (4:4) stoichiometry on purified HCN4 complexes.","evidence":"Single-molecule mass photometry of purified HCN4–TRIP8b complexes","pmids":["36225302"],"confidence":"Medium","gaps":["Single method confirmation","Whether partial occupancy occurs in vivo not addressed"]},{"year":2026,"claim":"The CNBD-antagonism mechanism was exploited therapeutically: a minimal TRIP8b-derived peptide that blocks cAMP-mediated HCN2 potentiation reduced pain hypersensitivity, establishing the TRIP8b–CNBD interface as a drug target.","evidence":"In vitro electrophysiology, viral DRG expression of TRIP8bnano, rat neuropathic pain behavioral assays","pmids":["42010827"],"confidence":"Medium","gaps":["Selectivity across HCN isoforms in vivo not fully characterized","Long-term efficacy and off-target effects unknown"]},{"year":null,"claim":"It remains unknown how a single protein partitions between its HCN channel auxiliary-subunit role and its peroxisomal PTS2 co-receptor role, and what governs this functional switch in vivo.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No study integrates the channel and peroxisomal functions","Regulatory determinants of partner selection (allostery, isoform, phosphorylation) not jointly tested","Structure of the CNBD-bound complex and of the cargo–PEX7–PEX5L assembly not determined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,4,16]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[4,13,15]},{"term_id":"GO:0038024","term_label":"cargo receptor activity","supporting_discovery_ids":[13]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,3,15]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[2]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[15]},{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[3,15]},{"term_id":"GO:0005777","term_label":"peroxisome","supporting_discovery_ids":[13]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[0,3,5,18]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[15,3]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[13]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,16]}],"complexes":["HCN channel auxiliary complex (4:4 HCN:TRIP8b)","cargo–PEX7–PEX5L PTS2 import complex"],"partners":["HCN1","HCN2","HCN4","PEX7","RAB8B","CLATHRIN","AP2","CIRL"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q8IYB4","full_name":"PEX5-related protein","aliases":["PEX2-related protein","PEX5-like protein","Peroxin-5-related protein","Peroxisome biogenesis factor 5-like","Tetratricopeptide repeat-containing Rab8b-interacting protein","Pex5Rp","TRIP8b"],"length_aa":626,"mass_kda":69.7,"function":"Accessory subunit of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, regulating their cell-surface expression and cyclic nucleotide dependence","subcellular_location":"Cytoplasm; Membrane","url":"https://www.uniprot.org/uniprotkb/Q8IYB4/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PEX5L","classification":"Not Classified","n_dependent_lines":19,"n_total_lines":1208,"dependency_fraction":0.015728476821192054},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PEX5L","total_profiled":1310},"omim":[{"mim_id":"611058","title":"PEROXISOME BIOGENESIS FACTOR 5-LIKE; PEX5L","url":"https://www.omim.org/entry/611058"},{"mim_id":"602780","title":"HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED POTASSIUM CHANNEL 1; HCN1","url":"https://www.omim.org/entry/602780"},{"mim_id":"600414","title":"PEROXISOME BIOGENESIS FACTOR 5; PEX5","url":"https://www.omim.org/entry/600414"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":46.5},{"tissue":"parathyroid gland","ntpm":28.4},{"tissue":"retina","ntpm":14.1}],"url":"https://www.proteinatlas.org/search/PEX5L"},"hgnc":{"alias_symbol":["PEX5R","PXR2","TRIP8b"],"prev_symbol":[]},"alphafold":{"accession":"Q8IYB4","domains":[{"cath_id":"1.25.40.10","chopping":"314-390","consensus_level":"medium","plddt":93.9552,"start":314,"end":390}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8IYB4","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8IYB4-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8IYB4-F1-predicted_aligned_error_v6.png","plddt_mean":63.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PEX5L","jax_strain_url":"https://www.jax.org/strain/search?query=PEX5L"},"sequence":{"accession":"Q8IYB4","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8IYB4.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8IYB4/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8IYB4"}},"corpus_meta":[{"pmid":"19555649","id":"PMC_19555649","title":"TRIP8b splice variants form a family of auxiliary subunits that regulate gating and trafficking of HCN channels in the brain.","date":"2009","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/19555649","citation_count":134,"is_preprint":false},{"pmid":"19439603","id":"PMC_19439603","title":"Alternatively spliced isoforms of TRIP8b differentially control h channel trafficking and function.","date":"2009","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19439603","citation_count":122,"is_preprint":false},{"pmid":"21593326","id":"PMC_21593326","title":"Deletion of the hyperpolarization-activated cyclic nucleotide-gated channel auxiliary subunit TRIP8b impairs hippocampal Ih localization and function and promotes antidepressant behavior in mice.","date":"2011","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/21593326","citation_count":108,"is_preprint":false},{"pmid":"19555650","id":"PMC_19555650","title":"Association with the auxiliary subunit PEX5R/Trip8b controls responsiveness of HCN channels to cAMP and adrenergic stimulation.","date":"2009","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/19555650","citation_count":105,"is_preprint":false},{"pmid":"21411649","id":"PMC_21411649","title":"TRIP8b regulates HCN1 channel trafficking and gating through two distinct C-terminal interaction sites.","date":"2011","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/21411649","citation_count":70,"is_preprint":false},{"pmid":"25197093","id":"PMC_25197093","title":"Structural basis for the mutual antagonism of cAMP and TRIP8b in regulating HCN channel function.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25197093","citation_count":70,"is_preprint":false},{"pmid":"21555075","id":"PMC_21555075","title":"TRIP8b splice forms act in concert to regulate the localization and expression of HCN1 channels in CA1 pyramidal neurons.","date":"2011","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/21555075","citation_count":63,"is_preprint":false},{"pmid":"21504900","id":"PMC_21504900","title":"Trafficking and gating of hyperpolarization-activated cyclic nucleotide-gated channels are regulated by interaction with tetratricopeptide repeat-containing Rab8b-interacting protein (TRIP8b) and cyclic AMP at distinct sites.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21504900","citation_count":54,"is_preprint":false},{"pmid":"11278749","id":"PMC_11278749","title":"Rab8b and its interacting partner TRIP8b are involved in regulated secretion in AtT20 cells.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11278749","citation_count":53,"is_preprint":false},{"pmid":"27400855","id":"PMC_27400855","title":"HCN-channel dendritic targeting requires bipartite interaction with TRIP8b and regulates antidepressant-like behavioral effects.","date":"2016","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/27400855","citation_count":44,"is_preprint":false},{"pmid":"22550182","id":"PMC_22550182","title":"Structure and stoichiometry of an accessory subunit TRIP8b interaction with hyperpolarization-activated cyclic nucleotide-gated channels.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22550182","citation_count":42,"is_preprint":false},{"pmid":"25800552","id":"PMC_25800552","title":"Structural mechanism for the regulation of HCN ion channels by the accessory protein TRIP8b.","date":"2015","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/25800552","citation_count":37,"is_preprint":false},{"pmid":"25538232","id":"PMC_25538232","title":"Mechanistic insights into PTS2-mediated peroxisomal protein import: the co-receptor PEX5L drastically increases the interaction strength between the cargo protein and the receptor PEX7.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25538232","citation_count":33,"is_preprint":false},{"pmid":"26459112","id":"PMC_26459112","title":"Reduction of thalamic and cortical Ih by deletion of TRIP8b produces a mouse model of human absence epilepsy.","date":"2015","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/26459112","citation_count":33,"is_preprint":false},{"pmid":"29168010","id":"PMC_29168010","title":"Modulation of thalamocortical oscillations by TRIP8b, an auxiliary subunit for HCN channels.","date":"2017","source":"Brain structure & function","url":"https://pubmed.ncbi.nlm.nih.gov/29168010","citation_count":32,"is_preprint":false},{"pmid":"23077068","id":"PMC_23077068","title":"TRIP8b-independent trafficking and plasticity of adult cortical presynaptic HCN1 channels.","date":"2012","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23077068","citation_count":31,"is_preprint":false},{"pmid":"22363812","id":"PMC_22363812","title":"Regulation of axonal HCN1 trafficking in perforant path involves expression of specific TRIP8b isoforms.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22363812","citation_count":24,"is_preprint":false},{"pmid":"28864772","id":"PMC_28864772","title":"Mechanism for the inhibition of the cAMP dependence of HCN ion channels by the auxiliary subunit TRIP8b.","date":"2017","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28864772","citation_count":24,"is_preprint":false},{"pmid":"32189562","id":"PMC_32189562","title":"The structure and function of TRIP8b, an auxiliary subunit of hyperpolarization-activated cyclic-nucleotide gated channels.","date":"2020","source":"Channels (Austin, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/32189562","citation_count":22,"is_preprint":false},{"pmid":"31492750","id":"PMC_31492750","title":"Phosphorylation of the HCN channel auxiliary subunit TRIP8b is altered in an animal model of temporal lobe epilepsy and modulates channel function.","date":"2019","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31492750","citation_count":20,"is_preprint":false},{"pmid":"18346465","id":"PMC_18346465","title":"Comparison of the PTS1- and Rab8b-binding properties of Pex5p and Pex5Rp/TRIP8b.","date":"2008","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/18346465","citation_count":19,"is_preprint":false},{"pmid":"36104739","id":"PMC_36104739","title":"PEX5R/Trip8b-HCN2 channel regulating neuroinflammation involved in perioperative neurocognitive disorders.","date":"2022","source":"Cell & bioscience","url":"https://pubmed.ncbi.nlm.nih.gov/36104739","citation_count":16,"is_preprint":false},{"pmid":"18620529","id":"PMC_18620529","title":"Analysis of proteins interacting with TRIP8b adapter.","date":"2008","source":"Biochemistry. Biokhimiia","url":"https://pubmed.ncbi.nlm.nih.gov/18620529","citation_count":14,"is_preprint":false},{"pmid":"23966674","id":"PMC_23966674","title":"Short- and long-term plasticity in CA1 neurons from mice lacking h-channel auxiliary subunit TRIP8b.","date":"2013","source":"Journal of neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/23966674","citation_count":14,"is_preprint":false},{"pmid":"28887304","id":"PMC_28887304","title":"Allostery between two binding sites in the ion channel subunit TRIP8b confers binding specificity to HCN channels.","date":"2017","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28887304","citation_count":10,"is_preprint":false},{"pmid":"35502931","id":"PMC_35502931","title":"Genetic variants in DDO and PEX5L in peroxisome-related pathways predict non-small cell lung cancer survival.","date":"2022","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/35502931","citation_count":9,"is_preprint":false},{"pmid":"24409334","id":"PMC_24409334","title":"TRIP8b is required for maximal expression of HCN1 in the mouse retina.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24409334","citation_count":9,"is_preprint":false},{"pmid":"32633755","id":"PMC_32633755","title":"Rational design of a mutation to investigate the role of the brain protein TRIP8b in limiting the cAMP response of HCN channels in neurons.","date":"2020","source":"The Journal of general physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32633755","citation_count":9,"is_preprint":false},{"pmid":"33946275","id":"PMC_33946275","title":"Characterization of the HCN Interaction Partner TRIP8b/PEX5R in the Intracardiac Nervous System of TRIP8b-Deficient and Wild-Type Mice.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33946275","citation_count":6,"is_preprint":false},{"pmid":"35623388","id":"PMC_35623388","title":"Discovery of a small-molecule inhibitor of the TRIP8b-HCN interaction with efficacy in neurons.","date":"2022","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35623388","citation_count":6,"is_preprint":false},{"pmid":"27911380","id":"PMC_27911380","title":"Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b.","date":"2016","source":"Journal of visualized experiments : JoVE","url":"https://pubmed.ncbi.nlm.nih.gov/27911380","citation_count":6,"is_preprint":false},{"pmid":"36852869","id":"PMC_36852869","title":"Characterization of Kv1.2-mediated outward current in TRIP8b-deficient mice.","date":"2023","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36852869","citation_count":3,"is_preprint":false},{"pmid":"21749376","id":"PMC_21749376","title":"Association of adaptor protein TRIP8b with clathrin.","date":"2011","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21749376","citation_count":2,"is_preprint":false},{"pmid":"36225302","id":"PMC_36225302","title":"Validation of the binding stoichiometry between HCN channels and their neuronal regulator TRIP8b by single molecule measurements.","date":"2022","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/36225302","citation_count":0,"is_preprint":false},{"pmid":"42010827","id":"PMC_42010827","title":"TRIP8bnano peptide prevents cAMP binding to HCN2 channels alleviating pain-like behaviors in rats with neuropathic pain.","date":"2026","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/42010827","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.06.20.660782","title":"Schizophrenia-associated 22q11.2 deletion elevates striatal acetylcholine and disrupts thalamostriatal projections to produce amotivation in mice","date":"2025-06-21","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.20.660782","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":19428,"output_tokens":5796,"usd":0.072612,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":14397,"output_tokens":5745,"usd":0.107805,"stage2_stop_reason":"end_turn"},"total_usd":0.180417,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2009,\n      \"finding\": \"TRIP8b (PEX5L) exists as at least nine alternative N-terminal splice isoforms in brain and functions as an auxiliary subunit of HCN1 channels: all isoforms inhibit channel opening by shifting activation to more negative potentials, while individual isoforms differentially downregulate or upregulate HCN1 surface expression.\",\n      \"method\": \"Heterologous expression of splice isoforms, electrophysiology, surface expression assays\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — replicated independently in two concurrent papers (PMID:19555649 and PMID:19439603) using electrophysiology and surface expression assays with multiple isoforms\",\n      \"pmids\": [\"19555649\", \"19439603\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PEX5R/TRIP8b was identified as the beta (auxiliary) subunit of HCN channels in mammalian brain by affinity purification and high-resolution mass spectrometry; coassembly with PEX5R/TRIP8b largely impairs cAMP-dependent activation of HCN2 and HCN4, while gating by phosphoinositides and basal voltage-dependence remain unaffected; de novo expression of PEX5R/TRIP8b in cardiomyocytes abolishes beta-adrenergic stimulation of HCN channels.\",\n      \"method\": \"Affinity purification, high-resolution mass spectrometry, electrophysiology in heterologous cells and cardiomyocytes\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — biochemical identification by MS plus functional electrophysiology in multiple cell types, published alongside independent replication\",\n      \"pmids\": [\"19555650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"TRIP8b was identified as a Rab8b-interacting protein via yeast two-hybrid screen from rat brain cDNA; interaction was verified by in vitro binding and co-immunoprecipitation; TRIP8b is present in both cytosolic and membrane fractions of AtT20 cells; overexpression of TRIP8b stimulates cAMP-induced ACTH secretion, implicating it in the regulated secretory pathway.\",\n      \"method\": \"Yeast two-hybrid, in vitro binding, co-immunoprecipitation, subcellular fractionation, ACTH secretion assay in stable cell lines\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal binding confirmed by multiple methods in single lab\",\n      \"pmids\": [\"11278749\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TRIP8b knockout mice show dramatically reduced Ih in hippocampal pyramidal neurons due to reduction of HCN channels on the neuronal surface and disrupted dendritic localization of HCN channels; absence of TRIP8b increases HCN subunit targeting to and degradation by lysosomes.\",\n      \"method\": \"Knockout mouse, electrophysiology, immunohistochemistry, subcellular fractionation, lysosome trafficking assay\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with multiple orthogonal readouts (electrophysiology, localization, lysosomal degradation) in vivo and in vitro\",\n      \"pmids\": [\"21593326\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TRIP8b interacts with HCN1 at two distinct C-terminal sites: (1) an upstream site where the HCN1 C-linker/cyclic nucleotide-binding domain (CNBD) interacts with an 80 aa domain in the conserved core of TRIP8b — necessary and sufficient for inhibition of channel opening and sufficient for downregulatory trafficking effects; (2) a downstream site where the HCN1 C-terminal SNL tripeptide interacts with the TRIP8b tetratricopeptide repeat (TPR) domain — stabilizes the complex and is required for upregulatory trafficking effects.\",\n      \"method\": \"Mutagenesis, co-immunoprecipitation, electrophysiology in heterologous cells and neurons\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — systematic mutagenesis of both interaction sites combined with electrophysiology and trafficking assays, consistent with independent structural data\",\n      \"pmids\": [\"21411649\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Isoform-wide disruption of TRIP8b/HCN1 interaction causes HCN1 mistargeting throughout CA1 somatodendritic compartments; selective removal of exons 1b and 2 leaves two hippocampal isoforms — TRIP8b(1a-4) promotes HCN1 surface expression in dendrites while TRIP8b(1a) suppresses HCN1 misexpression in axons — demonstrating that proper distal dendritic localization requires additive and subtractive sculpting by two distinct isoforms.\",\n      \"method\": \"Knockout mouse (isoform-specific), isoform-wide interaction mutant, viral overexpression in neurons, immunohistochemistry\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two complementary genetic mouse models with defined isoform rescue experiments\",\n      \"pmids\": [\"21555075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Interaction of TRIP8b with the HCN1 C-terminal SNL tripeptide (via TPR domain) governs channel trafficking effects, whereas TRIP8b interaction with the HCN1 CNBD affects both trafficking and gating; cAMP directly disrupts TRIP8b binding to the CNBD (requiring an arginine residue also required for cAMP binding), and elevated cAMP antagonizes TRIP8b-mediated upregulation of HCN1.\",\n      \"method\": \"Site-directed mutagenesis, electrophysiology, co-immunoprecipitation, biochemical competition assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — mutagenesis of both interaction sites combined with electrophysiology and biochemical competition, consistent with independent structural studies\",\n      \"pmids\": [\"21504900\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TRIP8b and HCN2 form an obligate 4:4 (tetrameric) complex; the TRIP8b TPR region binds the HCN C-terminal SNL tripeptide and the TRIP8b conserved region binds the HCN CNBD; X-ray crystal structure of the TRIP8b TPR domain in complex with the HCN2 C-terminal peptide was determined.\",\n      \"method\": \"Single-molecule fluorescence bleaching, fluorescence-detection size-exclusion chromatography, fluorescence anisotropy, X-ray crystallography\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure plus multiple orthogonal biophysical methods establishing stoichiometry and binding sites\",\n      \"pmids\": [\"22550182\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"NMR solution structure of the HCN2 CNBD (apo form) was determined and TRIP8b interaction site mapped; TRIP8b does not compete with cAMP for the same binding region on the CNBD but instead acts via an allosteric mechanism that prevents cAMP-induced conformational changes in the CNBD.\",\n      \"method\": \"NMR spectroscopy, structural mapping, conformational change analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structure with interaction site mapping in a single rigorous study\",\n      \"pmids\": [\"25197093\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"EPR and NMR studies show that TRIP8b binds to the apo (cAMP-free) state of the HCN2 CNBD without changing the overall domain structure, and the binding interface on the CNBD was identified, providing a structural framework for TRIP8b's reduction of cyclic nucleotide dependence.\",\n      \"method\": \"Electron paramagnetic resonance (EPR), NMR spectroscopy\",\n      \"journal\": \"Structure\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — two independent spectroscopic structural methods in a single rigorous study\",\n      \"pmids\": [\"25800552\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TRIP8b is required for HCN1 trafficking to dendrites but presynaptic (axonal terminal) cortical HCN1 expression and function is comparable between TRIP8b-null and wild-type mice, demonstrating compartment-selective roles of TRIP8b in HCN channel trafficking.\",\n      \"method\": \"TRIP8b knockout mouse, electrophysiology, electron microscopy\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with electrophysiology and EM in defined compartments\",\n      \"pmids\": [\"23077068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Specific TRIP8b isoforms regulate axonal HCN1 trafficking in perforant path; TRIP8b(1a) isoform promotes somatodendritic and reduces axonal HCN1 expression when overexpressed in entorhinal neurons, whereas TRIP8b(1a-4) does not alter axonal distribution.\",\n      \"method\": \"Knockout mouse (isoform-specific), viral overexpression in cultured neurons, immunohistochemistry\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isoform-specific mouse and overexpression in neurons, single lab\",\n      \"pmids\": [\"22363812\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The TPR domains of Pex5Rp/TRIP8b and Pex5p have distinct but overlapping substrate specificities for Rab8b and PTS1-like C-terminal peptides; changes in surrounding residues or conformational state of binding partners alter binding activities, showing the binding specificity of the TRIP8b TPR domain is context-dependent.\",\n      \"method\": \"Biochemical binding assays, peptide competition, mutagenesis\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biochemical methods in a single lab study\",\n      \"pmids\": [\"18346465\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"PEX5L acts as a co-receptor for PTS2-mediated peroxisomal import: in the presence of PEX5L, the interaction strength between PTS2 cargo and PEX7 is drastically increased; cargo binding is a prerequisite for PEX7–PEX5L interaction; overexpression of PTS2 cargo stimulates PEX7 transfer to peroxisomes, suggesting sequential formation of a trimeric cargo–PEX7–PEX5L complex is required for PTS2 import.\",\n      \"method\": \"Mammalian two-hybrid assay, overexpression, co-immunoprecipitation, peroxisomal transfer assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mammalian two-hybrid plus co-IP and peroxisomal transfer assays in single lab\",\n      \"pmids\": [\"25538232\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TRIP8b interacts with the calcium-independent receptor of alpha-latrotoxin (CIRL); affinity chromatography of brain extracts on immobilized TRIP8b identified clathrin and AP2 complex subunits as major TRIP8b-interacting proteins, suggesting a role in receptor-mediated endocytosis.\",\n      \"method\": \"Yeast two-hybrid, affinity chromatography, mass spectrometry\",\n      \"journal\": \"Biochemistry. Biokhimiia\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, affinity chromatography pulldown without reciprocal validation for most interactors\",\n      \"pmids\": [\"18620529\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TRIP8b directly interacts with clathrin through two short clathrin-binding motifs in its N-terminal (non-TPR) region; co-expression of HCN1 with TRIP8b in HEK293 cells translocates channels from cell surface to large intracellular puncta co-localizing with clathrin, early endosome, and lysosome markers; a clathrin-non-binding TRIP8b mutant fails to recruit clathrin to these puncta; TRIP8b is present in purified clathrin-coated vesicles from brain.\",\n      \"method\": \"In vitro binding assay, mutagenesis, co-immunoprecipitation, live/fixed cell imaging, purification of clathrin-coated vesicles\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro binding with mutagenesis plus cellular imaging and biochemical fractionation, single lab\",\n      \"pmids\": [\"21749376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TRIP8b reduces cAMP affinity for the HCN2 CNBD; using fluorescence anisotropy, biolayer interferometry, and DEER spectroscopy, TRIP8b was found to act predominantly as a partial competitive antagonist of cAMP at the CNBD binding site, largely competing with a portion of the cAMP-binding pocket rather than exclusively acting noncompetitively.\",\n      \"method\": \"Fluorescence anisotropy, biolayer interferometry, double electron-electron resonance (DEER) spectroscopy, kinetic modeling\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — three independent biophysical methods with quantitative modeling in a single rigorous study; note partial contradiction with allosteric model from PMID:25197093\",\n      \"pmids\": [\"28864772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Allosteric coupling between TRIP8b's TPR domains and its CNBD-binding domain confers binding specificity for HCN channels: binding at either the HCN CNBD site or the HCN C-terminal (SNL) site increases affinity at the other site, and this allostery also limits TRIP8b binding to PTS1-type substrates.\",\n      \"method\": \"Fluorescence polarization, co-immunoprecipitation, mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two orthogonal binding assays with mutagenesis, single lab\",\n      \"pmids\": [\"28887304\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Restoration of TRIP8b expression to the hippocampus of TRIP8b KO mice (viral rescue) was sufficient to reverse both impaired HCN channel dendritic trafficking and antidepressant-like behavioral effects; a TRIP8b mutant further impairing HCN channel trafficking increased the antidepressant-like phenotype, demonstrating that TRIP8b-mediated HCN channel trafficking bidirectionally controls antidepressant-like behavior.\",\n      \"method\": \"Viral rescue in KO mice, mutagenesis, immunohistochemistry, behavioral assays\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — bidirectional viral rescue in KO mice with orthogonal behavioral and cell biological readouts\",\n      \"pmids\": [\"27400855\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Phosphorylation of TRIP8b at Ser237 enhances its binding to HCN channels and influences channel gating by altering affinity for the HCN cytoplasmic domain; phospho-Ser237 TRIP8b is enriched in CA1 distal dendrites in vivo; this phosphorylation is reduced in the kainic acid model of TLE, correlating with HCN channel mislocalization.\",\n      \"method\": \"Phosphospecific antibody, co-immunoprecipitation, electrophysiology, immunohistochemistry, kainic acid TLE model\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phosphospecific antibody with functional binding and electrophysiology assays, single lab\",\n      \"pmids\": [\"31492750\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Two point mutations (N/A and C/D) in the N-bundle loop of HCN connecting the CNBD to the C-linker strongly reduce TRIP8b binding to the CNBD without altering cAMP affinity, dissociating TRIP8b's gating effects from its trafficking effects in cortical neurons.\",\n      \"method\": \"Structure-guided mutagenesis, binding assays, electrophysiology in cortical neurons\",\n      \"journal\": \"The Journal of general physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — rational structure-based mutagenesis validated functionally in neurons, single lab\",\n      \"pmids\": [\"32633755\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Single-molecule mass photometry of purified HCN4-TRIP8b complexes confirmed a 1:1 stoichiometry (four TRIP8b subunits per tetrameric HCN4 channel), independently validating the 4:4 stoichiometry reported by fluorescence bleaching.\",\n      \"method\": \"Single-molecule mass photometry\",\n      \"journal\": \"Frontiers in physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — single biophysical method (mass photometry) in a single lab, replicates prior fluorescence bleaching result\",\n      \"pmids\": [\"36225302\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TRIP8b is required for maximal HCN1 expression in the retina: in TRIP8b KO mice, HCN1 total protein is greatly reduced in retinal neurons but HCN1 surface trafficking is unaffected, indicating that in photoreceptors TRIP8b controls HCN1 abundance rather than localization.\",\n      \"method\": \"Knockout mouse, immunohistochemistry, Western blot, confocal microscopy\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with two orthogonal readouts (protein level and trafficking), single lab\",\n      \"pmids\": [\"24409334\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"A minimal peptide derivative of TRIP8b (TRIP8bnano) selectively prevents cAMP binding to the HCN2 CNBD and abolishes cAMP-mediated potentiation of HCN2 currents in dorsal root ganglion neurons; DRG-targeted expression of TRIP8bnano significantly reduced mechanical and thermal hypersensitivity in a rat neuropathic pain model.\",\n      \"method\": \"In vitro electrophysiology (HEK293T and DRG neurons), viral DRG expression, rat neuropathic pain behavioral assays\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional peptide inhibitor validated electrophysiologically and in vivo, single lab\",\n      \"pmids\": [\"42010827\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PEX5L/TRIP8b is a brain-specific auxiliary subunit of HCN channels that exists as multiple alternative splice isoforms and binds HCN pore-forming subunits at two distinct C-terminal sites — the CNBD (via the TRIP8b conserved core) and the C-terminal SNL tripeptide (via the TRIP8b TPR domain) — forming an obligate 4:4 complex; binding at the CNBD site (primarily by competitive/allosteric antagonism of cAMP) inhibits channel opening and controls cAMP responsiveness, while N-terminal splice-isoform-specific trafficking motifs differentially up- or down-regulate HCN surface expression and dendritic vs. axonal localization; TRIP8b also interacts with clathrin and Rab8b to regulate HCN endocytosis and lysosomal degradation; phosphorylation of TRIP8b at Ser237 modulates its HCN-binding affinity; and independently, PEX5L acts as a co-receptor in PTS2-mediated peroxisomal import by forming a trimeric complex with PEX7 and PTS2 cargo to stabilize import.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PEX5L/TRIP8b is a brain-enriched auxiliary (beta) subunit of hyperpolarization-activated cyclic-nucleotide-gated (HCN) channels that controls both HCN gating and subcellular trafficking [#0, #1]. It binds the pore-forming HCN subunits at two distinct C-terminal sites: an upstream interaction between the TRIP8b conserved core and the HCN C-linker/cyclic nucleotide-binding domain (CNBD), which is necessary and sufficient to inhibit channel opening, and a downstream interaction between the TRIP8b tetratricopeptide-repeat (TPR) domain and the HCN C-terminal SNL tripeptide, which stabilizes the complex and drives upregulatory trafficking; binding at the two sites is allosterically coupled, conferring HCN binding specificity [#4, #7, #17]. The structure of the TPR–SNL interface was solved crystallographically, and the assembled channel adopts an obligate 4:4 (one TRIP8b per HCN subunit) stoichiometry [#7, #21]. At the CNBD, TRIP8b binds the apo (cAMP-free) state and reduces cyclic-nucleotide sensitivity, acting predominantly as a partial competitive antagonist of cAMP, thereby suppressing cAMP/beta-adrenergic potentiation of HCN currents [#1, #16]. Through nine alternative N-terminal splice isoforms carrying distinct trafficking motifs and clathrin-binding sequences, TRIP8b sculpts HCN1 surface expression and somatodendritic-versus-axonal distribution, and routes HCN channels through clathrin-coated vesicles toward endosomes and lysosomes; loss of TRIP8b reduces dendritic Ih, mistargets HCN, and accelerates its lysosomal degradation [#0, #5, #15, #3]. TRIP8b-dependent HCN dendritic trafficking bidirectionally controls antidepressant-like behavior in mice, and Ser237 phosphorylation that enhances HCN binding is lost in a model of temporal lobe epilepsy, linking TRIP8b regulation to neuronal excitability disorders [#18, #19]. Independently of its channel role, PEX5L functions as a co-receptor for PTS2-mediated peroxisomal import, forming a trimeric cargo–PEX7–PEX5L complex in which cargo binding strengthens the PEX7 interaction [#13].\"\n,\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Before any channel role was known, the question was what cellular pathway TRIP8b participates in; identifying it as a Rab8b partner in the regulated secretory pathway gave the first functional foothold.\",\n      \"evidence\": \"Yeast two-hybrid from rat brain, in vitro binding, co-IP, and ACTH secretion assay in AtT20 cells\",\n      \"pmids\": [\"11278749\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not connect TRIP8b to HCN channels\", \"Physiological relevance of Rab8b binding to endogenous trafficking unresolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"It was unclear how the TRIP8b TPR domain achieves binding specificity; comparison with Pex5p showed overlapping, context-dependent recognition of Rab8b and PTS1-like C-terminal peptides.\",\n      \"evidence\": \"Biochemical binding, peptide competition, and mutagenesis of TPR domains\",\n      \"pmids\": [\"18346465\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No HCN substrate tested here\", \"Did not establish in-cell consequences of binding promiscuity\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"The defining advance was establishing TRIP8b as the HCN auxiliary beta subunit and showing it dually controls gating (inhibiting opening, suppressing cAMP/cyclic-nucleotide responsiveness) and isoform-dependent surface expression.\",\n      \"evidence\": \"Affinity purification + mass spectrometry, heterologous expression of multiple splice isoforms, electrophysiology, surface assays, and cardiomyocyte expression\",\n      \"pmids\": [\"19555649\", \"19439603\", \"19555650\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of the two binding sites not yet mapped\", \"Stoichiometry of the complex unknown\", \"Mechanism of cAMP antagonism unresolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"To explain how one protein both gates and traffics HCN, the two C-terminal interaction sites were dissected: the conserved-core/CNBD site mediates gating inhibition and downregulation, while the TPR/SNL site stabilizes the complex and drives upregulation, with cAMP directly disrupting CNBD binding.\",\n      \"evidence\": \"Systematic mutagenesis, co-IP, biochemical competition, and electrophysiology in heterologous cells and neurons\",\n      \"pmids\": [\"21411649\", \"21504900\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic structure of CNBD interface not yet solved\", \"Quantitative stoichiometry still inferred\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"It was unknown how TRIP8b removes HCN from the surface; identification of two N-terminal clathrin-binding motifs and recruitment of HCN to clathrin/endosome/lysosome puncta defined the endocytic mechanism.\",\n      \"evidence\": \"In vitro binding, mutagenesis, co-IP, cell imaging, and purification of brain clathrin-coated vesicles\",\n      \"pmids\": [\"21749376\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Adaptor requirements (e.g., AP2) only partially defined\", \"In vivo contribution of clathrin route to HCN turnover not quantified\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"To test physiological function, TRIP8b knockout and isoform-specific genetic models showed that proper distal dendritic HCN localization requires additive and subtractive sculpting by distinct isoforms, and that loss of TRIP8b reduces dendritic Ih and routes HCN to lysosomal degradation.\",\n      \"evidence\": \"Constitutive and isoform-specific knockout mice, viral isoform rescue, electrophysiology, immunohistochemistry, lysosome trafficking assays\",\n      \"pmids\": [\"21593326\", \"21555075\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trafficking machinery linking isoform motifs to compartments incompletely defined\", \"Cell-type specificity beyond hippocampus not addressed\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"The stoichiometry and TPR-site structure were resolved, establishing an obligate 4:4 complex and the atomic basis of the TPR–SNL interaction.\",\n      \"evidence\": \"Single-molecule fluorescence bleaching, FSEC, fluorescence anisotropy, and X-ray crystallography of the TPR–HCN2 peptide complex\",\n      \"pmids\": [\"22550182\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"CNBD-site structure not captured here\", \"Conformational basis of cAMP antagonism still open\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"To determine whether TRIP8b acts uniformly across neuronal compartments, knockout and isoform-overexpression studies revealed compartment-selective roles, with dendritic HCN1 requiring TRIP8b while axonal/presynaptic HCN1 was largely TRIP8b-independent and shaped by specific isoforms.\",\n      \"evidence\": \"Isoform-specific knockout mice, viral overexpression, electrophysiology, electron microscopy, immunohistochemistry\",\n      \"pmids\": [\"23077068\", \"22363812\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanistic basis of axonal vs dendritic targeting differences unresolved\", \"Isoform-specific binding partners not identified\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"The structural mechanism of cAMP desensitization was probed: NMR of the apo HCN2 CNBD mapped the TRIP8b site and indicated an allosteric mechanism preventing cAMP-induced conformational change rather than direct competition.\",\n      \"evidence\": \"NMR structure determination and interaction-site mapping with conformational analysis\",\n      \"pmids\": [\"25197093\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Allosteric vs competitive mechanism not definitively distinguished\", \"Dynamics of the apo-state interaction unresolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Two distinct roles outside the canonical model were established: TRIP8b controls HCN1 abundance (not surface trafficking) in retina, and PEX5L acts as a PTS2 import co-receptor via a cargo-dependent trimeric PEX7 complex.\",\n      \"evidence\": \"Knockout mouse with Western/immunohistochemistry (retina); mammalian two-hybrid, co-IP, and peroxisomal transfer assays (PTS2 import)\",\n      \"pmids\": [\"24409334\", \"25538232\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Tissue basis for abundance-vs-localization role difference unknown\", \"Structural basis of cargo–PEX7–PEX5L assembly not determined\", \"Relationship between channel and peroxisomal functions of the same gene unresolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Refining the CNBD mechanism, spectroscopic studies confirmed TRIP8b binds the apo CNBD without altering domain structure, providing a structural framework for reduced cyclic-nucleotide dependence.\",\n      \"evidence\": \"EPR and NMR spectroscopy with interface identification\",\n      \"pmids\": [\"25800552\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve competitive component of antagonism\", \"Kinetics of cAMP/TRIP8b exchange not measured\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"To connect molecular trafficking to behavior, viral rescue in TRIP8b KO mice demonstrated that TRIP8b-mediated HCN dendritic trafficking bidirectionally controls antidepressant-like behavior.\",\n      \"evidence\": \"Viral rescue with wild-type and trafficking-impairing mutants in KO mice, immunohistochemistry, behavioral assays\",\n      \"pmids\": [\"27400855\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Circuit-level mechanism linking Ih to behavior not defined\", \"Whether other ion channels contribute unresolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"The cAMP-antagonism mechanism was quantitatively refined to a predominantly partial competitive model, and allosteric coupling between TPR and CNBD-binding domains was shown to set HCN binding specificity over PTS1-type substrates.\",\n      \"evidence\": \"Fluorescence anisotropy, biolayer interferometry, DEER spectroscopy, kinetic modeling (mechanism); fluorescence polarization, co-IP, mutagenesis (allostery)\",\n      \"pmids\": [\"28864772\", \"28887304\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Partial contradiction with the purely allosteric model from earlier NMR work\", \"Physiological switch between channel and peroxisomal binding not defined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Post-translational regulation was identified: Ser237 phosphorylation enhances HCN binding and influences gating, is enriched in distal dendrites, and is lost with HCN mislocalization in an epilepsy model.\",\n      \"evidence\": \"Phosphospecific antibody, co-IP, electrophysiology, immunohistochemistry, kainic acid TLE model\",\n      \"pmids\": [\"31492750\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Kinase/phosphatase regulating Ser237 not identified\", \"Causal role of dephosphorylation in epileptogenesis not established\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Gating and trafficking functions were genetically separated using HCN N-bundle-loop mutations that abolish TRIP8b CNBD binding without altering cAMP affinity.\",\n      \"evidence\": \"Structure-guided HCN mutagenesis, binding assays, electrophysiology in cortical neurons\",\n      \"pmids\": [\"32633755\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mutations validated in a single neuronal context\", \"In vivo consequences of selective uncoupling not tested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"An independent biophysical method confirmed the one-TRIP8b-per-HCN-subunit (4:4) stoichiometry on purified HCN4 complexes.\",\n      \"evidence\": \"Single-molecule mass photometry of purified HCN4–TRIP8b complexes\",\n      \"pmids\": [\"36225302\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single method confirmation\", \"Whether partial occupancy occurs in vivo not addressed\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"The CNBD-antagonism mechanism was exploited therapeutically: a minimal TRIP8b-derived peptide that blocks cAMP-mediated HCN2 potentiation reduced pain hypersensitivity, establishing the TRIP8b–CNBD interface as a drug target.\",\n      \"evidence\": \"In vitro electrophysiology, viral DRG expression of TRIP8bnano, rat neuropathic pain behavioral assays\",\n      \"pmids\": [\"42010827\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Selectivity across HCN isoforms in vivo not fully characterized\", \"Long-term efficacy and off-target effects unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown how a single protein partitions between its HCN channel auxiliary-subunit role and its peroxisomal PTS2 co-receptor role, and what governs this functional switch in vivo.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No study integrates the channel and peroxisomal functions\", \"Regulatory determinants of partner selection (allostery, isoform, phosphorylation) not jointly tested\", \"Structure of the CNBD-bound complex and of the cargo–PEX7–PEX5L assembly not determined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 4, 16]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [4, 13, 15]},\n      {\"term_id\": \"GO:0038024\", \"supporting_discovery_ids\": [13]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 3, 15]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [15]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [3, 15]},\n      {\"term_id\": \"GO:0005777\", \"supporting_discovery_ids\": [13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 3, 5, 18]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [15, 3]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [13]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 16]}\n    ],\n    \"complexes\": [\n      \"HCN channel auxiliary complex (4:4 HCN:TRIP8b)\",\n      \"cargo–PEX7–PEX5L PTS2 import complex\"\n    ],\n    \"partners\": [\n      \"HCN1\",\n      \"HCN2\",\n      \"HCN4\",\n      \"PEX7\",\n      \"Rab8b\",\n      \"clathrin\",\n      \"AP2\",\n      \"CIRL\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}